首页> 美国卫生研究院文献>Cancer Management and Research >Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy

【2h】

Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy

机译：衍生中性白细胞与淋巴细胞比例的增加以及乳房成像报告和数据系统的分类预测新辅助化疗治疗的非远距离转移性HER2 +乳腺癌患者的生存率较低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThe prognostic role of the derived neutrophil-to-lymphocyte ratio (dNLR) in human patients with HER2+ breast cancer is not well understood. Here, we aimed to investigate the prognostic significance of dNLR in patients with HER2+ breast cancer undergoing neoadjuvant chemotherapy.

机译：引言嗜中性粒细胞与淋巴细胞之比（dNLR）在人类HER2 +乳腺癌患者中的预后作用尚不清楚。在这里，我们旨在研究dNLR在接受新辅助化疗的HER2 +乳腺癌患者中的预后意义。

著录项

期刊名称 Cancer Management and Research
作者
Yuyong Li; Yi Shao; Lishan Bai; Xingwei Zhou;
展开▼
作者单位

展开▼
年(卷),期 2018(10),-1
年度 2018
页码 3841–3847
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
breast cancer inflammation dNLR Breast Imaging-Reporting and Data System prognosis;

机译：乳腺癌;炎症;dNLR;乳房成像报告和数据系统;预后;

相似文献

外文文献
专利

1. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy [J] . Yuyong Li, Yi Shao, Lishan Bai, Cancer Management and Research . 2018,第2016期

机译：衍生的中性粒细胞与淋巴细胞比例的增加以及乳房成像报告和数据系统的分类预测，使用新辅助化疗治疗的非远距离转移性HER2 +乳腺癌患者的生存率较低
2. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy [J] . Yuyong Li, Yi Shao, Lishan Bai, Cancer Management and Research . 2018,第2013期

机译：衍生的中性粒细胞与淋巴细胞比例的增加以及乳房成像报告和数据系统的分类预测，使用新辅助化疗治疗的非远距离转移性HER2 +乳腺癌患者的生存率较低
3. Tumor response ratio predicts overall survival in breast cancer patients treated with neoadjuvant chemotherapy. [J] . Marian Miller, Rebecca A Ottesen, Joyce C Niland, Annals of surgical oncology . 2014,第10期

机译：肿瘤反应率可预测接受新辅助化疗的乳腺癌患者的总体生存率。
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer [O] . Toshiaki Iwase, Takafumi Sangai, Masahiro Sakakibara, -1

机译：中性粒细胞与淋巴细胞比例的增加预示着乳腺癌患者复发后的生存期较差
7. Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients [O] . Xiangting Qiu, Yucui Song, Yanxiang Cui, 2018

机译：增加中性粒细胞淋巴细胞比例独立预测非转移性三阴性乳腺癌患者的存活率差

Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅